Chlorthalidone Recall: Inventia 25 mg Tablets
Announced 2026-06-24 · FDA
Chlorthalidone tablets, USP 25 mg (Rx only) manufactured by Inventia Healthcare Limited are recalled for failed dissolution specifications. About 11,460 bottles distributed nationwide in the U.S. are affected. The batches are RISA24001 (100-tablet bottles) and RISB24002 (1000-tablet bottles), expiring 04/2027, with NDCs 64980-599-01 and 64980-599-10.
| Brand | Inventia Healthcare Limited |
|---|---|
| Product | Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambernath, M.I.D.C., Ambernath (East) - 421506, INDIA. Distributed by: Risiong Pharma Holdings, Inc., East Brunswick, NJ 08816. NDC 100-tablet bottle: 64980-599-01; NDC 1000-tablet bottle: 64980-599-10 |
| Reason | Failed Dissolution Specifications |
| Severity | moderate |
| Units affected | 11460 |
| Distribution | U.S. Nationwide. |
| Agency | FDA |
| Recall / campaign no. | [100 tablet bottle] Batch RISA24001; [1000 tablet bottle] Batch RISB24002; Exp. 04/2027 |
WHAT YOU SHOULD DO
- Stop using any recalled Chlorthalidone tablets immediately.
- Check if you have bottles from batch RISA24001 (100-tablet) or RISB24002 (1000-tablet) with expiration 04/2027; contact your pharmacist or healthcare provider for guidance on replacement or disposal.
- Follow the recall instructions provided by your pharmacist, healthcare provider, or the FDA for returning or disposing of recalled product.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.